ArticleCellular oncology (Dordrecht, Netherlands)2025

Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis.

Jung-Min Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.